A new shingles vaccine may help prevent cognitive decline, with a study from Stanford University indicating that vaccination in mid to later life could reduce new dementia cases by one in five over seven years. The research, published in the journal Nature, has sparked interest, leading Dr. Pascal Geldsetzer to seek funding for a clinical trial to further investigate the vaccine’s protective effects on brain health. Alongside the shingles vaccine, statins and weight loss drugs are also suggested to have similar beneficial impacts.
Full Article
Loading PerspectiveSplit analysis...
